Zobrazeno 1 - 10
of 538
pro vyhledávání: '"Akseli Hemminki"'
Publikováno v:
Cancer Medicine, Vol 13, Iss 15, Pp n/a-n/a (2024)
Abstract Esophageal cancer (EC) and gastric cancer (GC) are fatal cancers with a relatively late age of onset. Age is a negative risk factor for survival in many cancers and our aim was to analyze age‐specific survival in EC and GC using the recent
Externí odkaz:
https://doaj.org/article/c3262cb4c6174c95807e2a631f83dabb
Autor:
Kari Hemminki, Frantisek Zitricky, Kristina Sundquist, Jan Sundquist, Asta Försti, Akseli Hemminki, Otto Hemminki
Publikováno v:
Cancer Medicine, Vol 13, Iss 7, Pp n/a-n/a (2024)
Abstract Backround We wanted to characterize conditional survival in prostate cancer (PC) in Sweden around and after 2005 when the vast increase in incidence due to the opportunistic testing for prostate specific antigen (PSA) culminated. We hypothes
Externí odkaz:
https://doaj.org/article/965ca5766284445dbc5bc1c22b021024
Publikováno v:
Cancer Medicine, Vol 12, Iss 17, Pp 17945-17951 (2023)
Abstract Background Survival in breast cancer (BC) has developed favorably but late recurrences are still a problem. Methods We model survival data from the NORDCAN database and analyze 1‐, 5‐, and 10‐year relative survival and 5/1‐ and 10/5
Externí odkaz:
https://doaj.org/article/3d145f0e79434929af7a8c8a0c13088e
Publikováno v:
Cancers, Vol 16, Iss 12, p 2198 (2024)
Background: Despite treatment having improved through intensive surgical procedures and chemotherapy—and more recently, targeted therapies—ovarian cancer is the most fatal female cancer. As such, we wanted to analyze age-specific survival trends
Externí odkaz:
https://doaj.org/article/88faaec0f7d24d229ea638dd37bfe6d4
Publikováno v:
Cancer Medicine, Vol 12, Iss 9, Pp 10212-10221 (2023)
Abstract Background Gastric cancer (GC) and esophageal cancer (EC) are among the most fatal cancers and improving survival in them is a major clinical challenge. Nordic cancer data were recently released up to year 2019. These data are relevant for l
Externí odkaz:
https://doaj.org/article/74cf15bc6fca43019dad1946dd56e856
Autor:
Frantisek Zitricky, Anni I. Koskinen, Otto Hemminki, Asta Försti, Akseli Hemminki, Kari Hemminki
Publikováno v:
Cancer Medicine, Vol 13, Iss 1, Pp n/a-n/a (2024)
Abstract Background Cancers of the head and neck (HN) are heterogeneous tumors with incidence rates varying globally. In Northern Europe oral and oropharyngeal cancers are the most common individual types. Survival for HN varies by individual tumor t
Externí odkaz:
https://doaj.org/article/1d6dae5055bd49eaa77262308b4cfbbc
Autor:
Tatiana V. Kudling, James H.A. Clubb, Santeri Pakola, Dafne C.A. Quixabeira, Iris A.K. Lähdeniemi, Camilla Heiniö, Victor Arias, Riikka Havunen, Victor Cervera-Carrascon, Joao M. Santos, Eva Sutinen, Jari Räsänen, Kristian Borenius, Mikko I. Mäyränpää, Eero Aaltonen, Suvi Sorsa, Otto Hemminki, Anna Kanerva, Emmy W. Verschuren, Ilkka Ilonen, Akseli Hemminki
Publikováno v:
OncoImmunology, Vol 12, Iss 1 (2023)
ABSTRACTLung cancer remains among the most difficult-to-treat malignancies and is the leading cause of cancer-related deaths worldwide. The introduction of targeted therapies and checkpoint inhibitors has improved treatment outcomes; however, most pa
Externí odkaz:
https://doaj.org/article/0795eae91aef4daa81fbde09829253f2
Autor:
Akseli Hemminki, Anna Kanerva, João Manuel Santos, Saru Basnet, Santeri A Pakola, James Clubb, Elise Jirovec, Tatiana Kudling, Lyna Haybout, Mirte Van der Heijden, Susanna AM Grönberg-Vähä-Koskela, Victor Arias, Dafne Alves Quixabeira
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/332611c01f8241829f848b5b92839cb7
Autor:
Tuomo Alanko, Akseli Hemminki, Víctor Cervera-Carrascón, João Santos, Riikka Havunen, Juha Kononen, Jorma Sormunen, Katriina Peltola, Riitta Korpisaari, Marjut Jaakkola, Suvi Sorsa, Santeri A Pakola, James Clubb, Elise Jirovec, Dafne CA Quixabeira, Tatiana Kudling, Lyna Haybout, Claudia Kistler
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/a0e17f652b7e484eace4f6c9324cd603
Autor:
Tuomo Alanko, Akseli Hemminki, Víctor Cervera-Carrascón, João Santos, Riikka Havunen, Juha Kononen, Jorma Sormunen, Katriina Peltola, Riitta Korpisaari, Susanna Juteau, Marjut Jaakkola, Suvi Sorsa, Santeri A Pakola, James Clubb, Elise Jirovec, Dafne CA Quixabeira, Tatiana Kudling, Lyna Haybout, Claudia Kistler
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/218c591c834f4171bd71d0925ee0f06c